Saturday, April 12, 2025
HomePharma

Pharma

Pharma

Artiva Biotherapeutics Announces FDA Clearance of IND for AlloNK® Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis

Life Sciences Times - 0
Pharma

The Access to Advanced Health Institute Receives $18 Million Award to Develop a Temperature Stable, Single-Dose Chikungunya RNA Vaccine Through a Phase 1 Clinical...

Life Sciences Times - 0
Pharma

U.S. FDA Approves Merck’s ERVEBO® (Ebola Zaire Vaccine, Live) for Use in Children 12 Months of Age and Older

Life Sciences Times - 0
Pharma

AVM Biotechnology Announces Twenty-Eight (28) Solid Tumor and Blood Cancer Patients have been Treated with Immunomodulatory AVM0703 through Expanded Access/Compassionate Use Programs

Life Sciences Times - 0
Pharma

FDA Approves Harm Reduction Therapeutics’ Over-the-Counter Opioid Overdose Reversal Medication

Life Sciences Times - 0
Pharma

Melinta Therapeutics Announces Commercial Availability of REZZAYO™

Life Sciences Times - 0
Pharma

Jardiance® (empagliflozin) approved in the EU for the treatment of adults with chronic kidney disease

Life Sciences Times - 0
Pharma

FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis

Life Sciences Times - 0
Pharma

First Patient Dosed in SAR’514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma

Life Sciences Times - 0
Pharma

U.S. FDA Approves First Anti-Inflammatory Drug for Cardiovascular Disease

Life Sciences Times - 0
Pharma

Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Life Sciences Times - 0
Pharma

Novaliq Announces FDA Approval of VEVYE™ (Cyclosporine Ophthalmic Solution) 0.1% for the Treatment of the Signs and Symptoms of Dry Eye Disease

Life Sciences Times - 0
1...91011...61Page 10 of 61

Most Read

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: [email protected]

FOLLOW US

© Newspaper WordPress Theme by TagDiv